Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA NDI Notification Draft Guidance Contradicts Final Rule – Ullman

This article was originally published in The Tan Sheet

Executive Summary

FDA contradicts its final rule on new dietary ingredient notifications with its draft guidance requiring notifications for all supplements containing an NDI, food and drug attorney Marc Ullman contends.
Advertisement

Related Content

Attorneys See FDA Rulemaking By Guidance In NDI Notification Draft
Attorneys See FDA Rulemaking By Guidance In NDI Notification Draft
Attorneys See FDA Rulemaking By Guidance In NDI Notification Draft
Attorneys See FDA Rulemaking By Guidance In NDI Notification Draft
Herbalife Proposes FDA Use NDI Master Files To Reduce Notification Burden
Herbalife Proposes FDA Use NDI Master Files To Reduce Notification Burden
Herbalife Proposes FDA Use NDI Master Files To Reduce Notification Burden
Industry Pushes FDA For Narrower Policy On NDI Notifications
Industry Pushes FDA For Narrower Policy On NDI Notifications
NDI Guidance Is “Radical Departure” From DSHEA; More Comment Time Needed – Attorney

Topics

Advertisement
UsernamePublicRestriction

Register

PS105237

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel